Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC industry pollution prevention efforts limited by GMPs, NDMA tells EPA.

This article was originally published in The Tan Sheet

Executive Summary

EPA ABANDONMENT OF ADDED CHEMICAL USE REPORTING RECOMMENDED BY NDMA in Dec. 20 comments submitted to the Environmental Protection Agency. The Nonprescription Drug Manufacturers Association maintains that reporting of data beyond what is already available in the Toxic Release Inventory (TRI) database -- information collected under the Emergency Planning and Community Right-to-Know Act (EPCRA) and the Pollution Prevention Act (PPA) -- would "confuse, not educate, communities and workers." The NDMA comments respond to an Oct. 1 EPA advance notice of proposed rulemaking.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel